Defendant

A and B Imprisonment for one year, Defendant C, D and J respectively, and Defendant L for 10 months and 8 months, respectively.

Punishment of the crime

Defendant A is working as the head of the production headquarters of the Chungcheongnambuk Factory, which exercises overall control over the production of medicinal herbs in M Co., Ltd. (hereinafter referred to as “M”) established for the purpose of importing, manufacturing, and selling medicinal herbss.

No one shall manufacture or sell drugs not listed in the biological preparations and the Korean Pharmacopoeia, in conformity with the nature, state, quality, etc. of drugs prescribed in the standards set by the Korean Pharmacopoeia Standard Book, and shall manufacture or sell drugs not in compliance with the said standards.

Defendant

A, as a result of the examination conducted by the above company itself by Q Research Institute for herb drugs imported from China, etc., pursuant to the result of the examination conducted by the above company's own Q Research Institute, it would, in principle, be discarded, but it would prevent enormous loss of the company, thereby manipulating the test results issued by the above research institute through D, which is the president of the above company's representative director B, the president of the joint representative director of C, the director of the headquarters of C, the head of Q Research Institute, and the Strategic Management Committee, as if they were "

Defendant

A On April 16, 2013, as a result of the inspection by the Q Research Institute of M self- Q2 about the connection of medicinal herbs imported from China from the institute of Q2 in the Q2 in the R of Chungcheongnam-gun, Chungcheongnam-do, Q200, a loss would occur if a bailee 30pm is found to be more than 111 times more than 3,340pm in conformity with the distribution standards, and is discarded, even if it is found to be inappropriate for distribution standards and disposed of, it would result in the loss. Accordingly, D shall operate a false test report as if it is appropriate for D to meet the distribution standards, and D shall enter the standard value of the connection of the standard value of the connection, which is the oriental medicine, into one pm in conformity with the distribution standards, and enter the test report into the "conformity" as a result of the determination, and thereafter thereafter, shall look at the above beer, the oriental medicine, a Chinese medicine, at the factory.